Back
 IJCM  Vol.7 No.3 , March 2016
Impact of Maintenance Steroids versus Rapid Steroid Withdrawal in African-American Kidney Transplant Recipients: Comparison of Two Urban Centers
Abstract: Background: Rapid steroid withdrawal (RSW) is used increasingly in kidney transplantation but long-term outcomes in African-American (AA) recipients are not well known. We compared 1 and 5 year transplant outcomes in a large cohort of AA patients who were maintained on continued steroid therapy (CST) to those who underwent RSW. Methods: Post-transplant courses of A as receiving kidney allografts from 2003-2011 at two urban transplant centers in Chicago were followed. Prior to outcome analysis, we used Inverse Probability of Treatment Weights (IPTW) to match the two groups on a set of baseline risk factors. Graft and patient survival, GFR at 1 and 5 years, incidence and type of rejection, incidence of post-transplant diabetes mellitus (PTDM), delayed graft function, CMV and BK viremia were compared. Results: There were 150 AA recipients in the CST analytic group and 157 in the RSW analytic group. Graft and patient survival was similar between the two groups. Rates of CMV viremia were higher in the RSW compared to the CST analytic group at 1 year. Biopsy-proven acute rejection and PTDM were similar between the RSW and CST groups. Conclusions: In AA recipients, RSW has similar long-term outcomes to CST.
Cite this paper: Chon, W. , Desai, A. , Wing, C. , Arwindekar, D. , Y. S. Tang, I. , Josephson, M. and Akkina, S. (2016) Impact of Maintenance Steroids versus Rapid Steroid Withdrawal in African-American Kidney Transplant Recipients: Comparison of Two Urban Centers. International Journal of Clinical Medicine, 7, 204-216. doi: 10.4236/ijcm.2016.73021.
References

[1]   Luan, F.L., Steffick, D.E., Gadegbeku, C., Norman, S.P., Wolfe, R. and Ojo, A.O. (2009) Graft and Patient Survival in Kidney Transplant Recipients Selected for de Novo Steroid-Free Maintenance Immunosuppression. American Journal of Transplantation, 9, 160-168.
http://dx.doi.org/10.1111/j.1600-6143.2008.02442.x

[2]   Matas, A.J., et al. (2005) Prednisone-Free Maintenance Immunosuppression—A 5-Year Experience. American Journal of Transplantation, 5, 2473-2478.
http://dx.doi.org/10.1111/j.1600-6143.2005.01051.x

[3]   Zhang, X., Huang, H.J., Han, S., Fu, S.X. and Wang, L.M. (2013) Is It Safe to Withdraw Steroids within Seven Days of Renal Transplantation? Clinical Transplantation, 27, 1-8.
http://dx.doi.org/10.1111/ctr.12015

[4]   Iwamoto, H., Hama, K., Konno, O., Yokoyama, T., Kihara, Y., Jojima, Y., Nakamura, Y., Takeuchi, H. and Shimazu, M. (2012) Early Steroid Withdrawal in Adult Kidney Transplantation at a Single Center. Transplantation Proceedings, 44, 179-181.
http://dx.doi.org/10.1016/j.transproceed.2011.12.068

[5]   Knight, S.R. and Morris, P.J. (2011) Interaction between Maintenance Steroid Dose and the Risk/Benefit of Steroid Avoidance and Withdrawal Regimens Following Renal Transplantation. Transplantation, 92, e63-e64.
http://dx.doi.org/10.1097/TP.0b013e3182370611

[6]   Pascual, J. (2011) Steroid Avoidance or Withdrawal in Kidney Transplantation. Current Opinion in Organ Transplantation, 16, 600-605.
http://dx.doi.org/10.1097/MOT.0b013e32834c23fa

[7]   Pascual, J., et al. (2012) Very Early Steroid Withdrawal or Complete Avoidance for Kidney Transplant Recipients: A Systematic Review. Nephrology Dialysis Transplantation, 27, 825-832.
http://dx.doi.org/10.1093/ndt/gfr374

[8]   Pascual, J., Galeano, C., Quereda, C., Royuela, A. and Zamora, J. (2009) Steroid Avoidance or Withdrawal for Kidney Transplant Recipients. Cochrane Database of Systematic Reviews, CD005632.
http://dx.doi.org/10.1002/14651858.cd007669

[9]   Woodle, E.S., et al. (2008) A Prospective, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Comparing Early (7 day) Corticosteroid Cessation versus Long-Term, Low-Dose Corticosteroid Therapy. Annals of Surgery, 248, 564-577.
http://dx.doi.org/10.1097/sla.0b013e318187d1da

[10]   Vincenti, F., et al. (2008) A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients. American Journal of Transplantation, 8, 307-316.
http://dx.doi.org/10.1111/j.1600-6143.2007.02057.x

[11]   Rajab, A., Pelletier, R.P., Henry, M.L. and Ferguson, R.M. (2006) Excellent Clinical Outcomes in Primary Kidney Transplant Recipients Treated with Steroid-Free Maintenance Immunosuppression. Clinical Transplantation, 20, 537-546.
http://dx.doi.org/10.1111/j.1399-0012.2006.00521.x

[12]   Kumar, M.S., et al. (2006) Safety and Efficacy of Steroid Withdrawal Two Days after Kidney Transplantation: Analysis of Results at Three Years. Transplantation, 81, 832-839.
http://dx.doi.org/10.1097/01.tp.0000203558.34739.c6

[13]   Teraoka, S., et al. (2005) Comparative Study of Clinical Outcome in Kidney Transplantation between Early Steroid Withdrawal Protocol Using Basiliximab, Calcineurin Inhibitor, and Mycophenolate Mofetil and Triple Regimen Consisting of Calcineurin Inhibitor, Mycophenolate Mofetil, and Steroid. Transplantation Proceedings, 37, 791-794.
http://dx.doi.org/10.1016/j.transproceed.2004.12.185

[14]   Laftavi, M.R., et al. (2005) Randomized Prospective Trial of Early Steroid Withdrawal Compared with Low-Dose Steroids in Renal Transplant Recipients Using Serial Protocol Biopsies to Assess Efficacy and Safety. Surgery, 137, 364-371.
http://dx.doi.org/10.1016/j.surg.2004.10.013

[15]   Woodle, E.S., et al. (2005) A Multicenter Pilot Study of Early (4-Day) Steroid Cessation in Renal Transplant Recipients under Simulect, Tacrolimus and Sirolimus. American Journal of Transplantation, 5, 157-166.
http://dx.doi.org/10.1111/j.1600-6143.2004.00655.x

[16]   Khwaja, K., et al. (2004) Outcome at 3 Years with a Prednisone-Free Maintenance Regimen: A Single-Center Experience with 349 Kidney Transplant Recipients. American Journal of Transplantation, 4, 980-987.
http://dx.doi.org/10.1111/j.1600-6143.2004.00443.x

[17]   Aull, M.J., et al. (2012) Early Corticosteroid Withdrawal in Recipients of Renal Allografts: A Single-Center Report of Ethnically Diverse Recipients and Recipients of Marginal Deceased-Donor Kidneys. Transplantation, 94, 837-844.
http://dx.doi.org/10.1097/TP.0b013e318265c461

[18]   Padiyar, A., Augustine, J.J., Bodziak, K.A., Aeder, M., Schulak, J.A. and Hricik, D.F. (2010) Influence of African-American Ethnicity on Acute Rejection after Early Steroid Withdrawal in Primary Kidney Transplant Recipients. Transplantation Proceedings, 42, 1643-1647.
http://dx.doi.org/10.1016/j.transproceed.2010.02.081

[19]   Anil Kumar, M.S., Khan, S., Ranganna, K., Malat, G., Sustento-Reodica, N. and Meyers, W.C. (2008) Long-Term Outcome of Early Steroid Withdrawal after Kidney Transplantation in African American Recipients Monitored by Surveillance Biopsy. American Journal of Transplantation, 8, 574-585.
http://dx.doi.org/10.1111/j.1600-6143.2007.02099.x

[20]   Zeng, X., et al. (2007) Intermediate-Term Outcomes with Early Steroid Withdrawal in African-American Renal Transplant Recipients Undergoing Surveillance Biopsy. Surgery, 142, 538-544; Discussion 544-545.
http://dx.doi.org/10.1016/j.surg.2007.07.006

[21]   Haririan, A., Sillix, D.H., Morawski, K., El-Amm, J.M., Garnick, J., Doshi, M.D., West, M.S. and Gruber, S.A. (2006) Short-Term Experience with Early Steroid Withdrawal in African-American Renal Transplant Recipients. American Journal of Transplantation, 6, 2396-2402.
http://dx.doi.org/10.1111/j.1600-6143.2006.01477.x

[22]   Boardman, R.E., et al. (2005) African American Renal Transplant Recipients Benefit from Early Corticosteroid Withdrawal under Modern Immunosuppression. Transplantation Proceedings, 37, 814-816.
http://dx.doi.org/10.1016/j.transproceed.2004.12.071

[23]   Schold, J.D., Srinivas, T.R., Braun, W.E., Shoskes, D.A., Nurko, S. and Poggio, E.D. (2011) The Relative Risk of Overall Graft Loss and Acute Rejection Among African American Renal Transplant Recipients Is Attenuated with Advancing Age. Clinical Transplantation, 25, 721-730.
http://dx.doi.org/10.1111/j.1399-0012.2010.01343.x

[24]   Khwaja, K., et al. (2004) Rapid Discontinuation of Prednisone in Higher-Risk Kidney Transplant Recipients. Transplantation, 78, 1397-1399.
http://dx.doi.org/10.1097/01.TP.0000136964.59494.FF

[25]   Bang, H. and Robins, J.M. (2005) Doubly Robust Estimation in Missing Data and Causal Inference Models. Biometrics, 61, 962-973.
http://dx.doi.org/10.1111/j.1541-0420.2005.00377.x

[26]   Stuart, E.A. and Rubin, D.B. (2007) Best Practices in Quasi-Experimental Designs: Matching Methods for Causal Inference. In: Osborne, J, Ed., Best Practices in Quantitative Methods, Thousand Oaks, Sage Publications, 155-176.

[27]   Ho, D.E., Imai, K., King, G. and Stuart, E.A. (2007) Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference. Political Analysis, 15, 199-236.
http://dx.doi.org/10.1093/pan/mpl013

[28]   (SRTR) O.P.a.T.N.O.a.S.R.o.T.R. OPTN/SRTR 2011 Annual Data Report—Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 2001-2010—Recipients with Kidney Transplants. Table 5.6 g. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2012.
http://www.srtr.org/annual_Reports/2011/506d_ki.aspx

[29]   (SRTR) O.P.a.T.N.O.a.S.R.o.T.R. OPTN/SRTR 2011 Annual Data Report—Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 2002 to 2011—Recipients with Kidney Transplants. Table 5.6 d. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2012.
http://www.srtr.org/annual_Reports/2011/506g_ki.aspx

[30]   Knight, S.R. and Morris, P.J. (2010) Steroid Avoidance or Withdrawal after Renal Transplantation Increases the Risk of Acute Rejection But Decreases Cardiovascular Risk. A Meta-Analysis. Transplantation, 89, 1-14.
http://dx.doi.org/10.1097/TP.0b013e3181c518cc

[31]   Opelz, G. and Dohler, B. (2013) Association between Steroid Dosage and Death with a Functioning Graft after Kidney Transplantation. American Journal of Transplantation, 13, 2096-2105.
http://dx.doi.org/10.1111/ajt.12313

[32]   Gonzalez-Molina, M., et al. (2010 Effect of Long-Term Steroid Withdrawal in Renal Transplant Recipients: A Retrospective Cohort Study. NDT Plus, 3, ii32-ii36.

[33]   Rike, A.H., et al. (2008) Cardiovascular Risk, Cardiovascular Events, and Metabolic Syndrome in Renal Transplantation: Comparison of Early Steroid Withdrawal and Chronic Steroids. Clinical Transplantation, 22, 229-235.
http://dx.doi.org/10.1111/j.1399-0012.2007.00779.x

[34]   Kasiske, B.L., et al. (2003) Diabetes Mellitus after Kidney Transplantation in the United States. American Journal of Transplantation, 3, 178-185.
http://dx.doi.org/10.1034/j.1600-6143.2003.00010.x

[35]   Midtvedt, K., et al. (2004) Insulin Resistance after Renal Transplantation: The Effect of Steroid Dose Reduction and Withdrawal. Journal of the American Society of Nephrology, 15, 3233-3239.
http://dx.doi.org/10.1097/01.asn.0000145435.80005.1e

[36]   Pirsch, J.D., Henning, A.K., First, M.R., Fitzsimmons, W., Gaber, A.O., Reisfield, R., Shihab F. and Woodle, E.S. (2015) New-Onset Diabetes after Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial. American Journal of Transplantation, 15, 1982-1990.
http://dx.doi.org/10.1111/ajt.13247

[37]   Ibrahim, H., et al. (2006) Graft Loss from Recurrent Glomerulonephritis Is Not Increased with a Rapid Steroid Discontinuation Protocol. Transplantation, 81, 214-219.
http://dx.doi.org/10.1097/01.tp.0000188656.44326.53

[38]   Boardman, R., et al. (2005) Early Steroid Withdrawal Does Not Increase Risk for Recurrent Focal Segmental Glomerulosclerosis. Transplantation Proceedings, 37, 817-818.
http://dx.doi.org/10.1016/j.transproceed.2004.12.065

[39]   Clayton, P., McDonald, S. and Chadban, S. (2011) Steroids and Recurrent IgA Nephropathy after Kidney Transplantation. American Journal of Transplantation, 11, 1645-1649.
http://dx.doi.org/10.1111/j.1600-6143.2011.03667.x

[40]   Von Visger, J.R., et al. (2014) The Risk of Recurrent IgA Nephropathy in a Steroid-Free Protocol and Other Modifying Immunosuppression. Clinical Transplantation, 28, 845-854.
http://dx.doi.org/10.1111/ctr.12389

 
 
Top